Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now presents the clinical trial record for perioperative CV301 vaccination with nivolumab and chemotherapy for metastatic colorectal cancer, including study design, eligibility, outcomes, locations, and record history. It identifies the study as terminated and no longer recruiting participants.
    Difference
    64%
    Check dated 2026-11-08T04:34:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T01:34:59.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the ClinicalTrials.gov page, announcing updates and FAQs about the website transition and stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T01:27:45.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:10:49.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:45:13.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 tag appears, and a large set of study-related sections and personnel/location details are removed, changing how the study record is presented.
    Difference
    20%
    Check dated 2026-09-20T00:30:11.000Z thumbnail image

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.